Alumis (ALMS) Cash & Equivalents (2023 - 2026)
Alumis (ALMS) posted quarterly Cash & Equivalents of $89.7 million for Q4 2025, down 47.11% year-over-year from $169.5 million in Q4 2024, and up 37.41% quarter-over-quarter from $65.3 million in Q3 2025.
Analysis
Alumis (ALMS) Cash & Equivalents (2023 - 2026) Analysis & Trends
Alumis (ALMS) has reported Cash & Equivalents for 3 consecutive years, with $89.7 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Cash & Equivalents fell 47.11% year-over-year to $89.7 million; the TTM figure through Dec 2025 stood at $89.7 million (down 47.11% YoY), while the FY2025 annual figure was $89.7 million, down 47.11% from the prior year.
- Cash & Equivalents climbed to $89.7 million in Q4 2025 per ALMS's latest filing, from $65.3 million in the prior quarter.
- Across five years, Cash & Equivalents topped out at $213.4 million in Q3 2024 and bottomed at $46.0 million in Q4 2023.
- Historically, Cash & Equivalents has averaged $115.0 million across 3 years, with a median of $112.1 million in 2024.
- Annual changes were most pronounced in 2024 — Cash & Equivalents soared 295.68% — and 2025, when it tumbled 69.42%.
- Alumis' Cash & Equivalents stood at $46.0 million in 2023, then soared by 268.57% to $169.5 million in 2024, then sank by 47.11% to $89.7 million in 2025.
- Business Quant data shows ALMS's Cash & Equivalents at $89.7 million in Q4 2025, $65.3 million in Q3 2025, and $151.8 million in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.43 Bn | 130.58 Bn | 2.84 Bn | 6.14 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 2.46 Bn |
| 3 | Argenx Se | 63.34 Bn | 58.15 Bn | 1.37 Bn | 3.58 Bn |
| 4 | Moderna | 57.98 Bn | 52.85 Bn | 52.00 Mn | 1.72 Bn |
| 5 | Revolution Medicines | 43.98 Bn | 43.98 Bn | - | 815.44 Mn |
| 6 | BeOne Medicines | 39.92 Bn | 34.82 Bn | 1.53 Bn | 5.10 Bn |
| 7 | Alnylam Pharmaceuticals | 35.42 Bn | 32.11 Bn | 992.69 Mn | 1.71 Bn |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - | 811.99 Mn |
| 9 | Insmed | 27.36 Bn | 26.20 Bn | 358.27 Mn | 544.80 Mn |
| 10 | Alumis | 1.41 Bn | 912.61 Mn | - | 63.71 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 63.71 Mn |
| Dec 31, 2025 | 89.67 Mn |
| Sep 30, 2025 | 65.26 Mn |
| Jun 30, 2025 | 151.75 Mn |
| Mar 31, 2025 | 128.54 Mn |
| Dec 31, 2024 | 169.53 Mn |
| Sep 30, 2024 | 213.42 Mn |
| Jun 30, 2024 | 155.11 Mn |
| Mar 31, 2024 | 112.07 Mn |
| Dec 31, 2023 | 46.00 Mn |
| Sep 30, 2023 | 53.94 Mn |
| Jun 30, 2023 | 79.56 Mn |